Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with RNA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
RNA
Atrium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
RNA
Atrium Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No disclosed counterparties: RNA.
Only RNA
0
None
Role chip = supplier or customer
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,350.00
· delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
RNA
Atrium Therapeutics, Inc.
Change
8.34
· pre 8.34
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$142.3M
Revenue
$3M
Q2 FY26
Revenue
—
vs
Compare
Pre-market
Nov 6 '26
delayed
LLY
ELI Lilly & Co
vs
RNA
Atrium Therapeutics, Inc.
1,371.32
pre 1,350.00
delayed
Price
8.34
pre 8.34
delayed
$1.2T
Mkt cap
$142.3M
Q3 FY26
$24.4B
Revenue
$3M
Q2 FY26
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,371.32
vs
RNA
8.34
Pre-market
Nov 6 '26
delayed